NCT06602271Phase 3Recruiting

PF614 Analgesic Activity in Acute Postoperative Pain (PF614-301)

Study sponsor: Ensysce Biosciences

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2026-08Estimated
Enrollment · participants320Estimated
Source updated2026-01-22Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 3 fields changed

Planned enrollment increased by 20 participants

Before: 300 participants (planned). After: 320 participants (planned).

Primary completion date changed

Before: Mar 2026. After: Aug 2026.

Recruitment status changed

Before: Not yet recruiting. After: Recruiting.

Check registry source